欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2023, Vol. 28 ›› Issue (1): 59-65.doi: 10.12092/j.issn.1009-2501.2023.01.008

• 药物治疗学 • 上一篇    下一篇

艾司氯胺酮复合舒芬太尼对胸腔镜肺癌根治术后情绪及镇痛的影响

苏洋,周峰,丁金磊   

  1. 大连医科大学附属第二医院麻醉科,大连 116000,辽宁
  • 收稿日期:2022-10-28 修回日期:2022-12-20 出版日期:2023-01-26 发布日期:2023-02-14
  • 通讯作者: 周峰,男,硕士生导师,主任医师,研究方向:麻醉与镇痛。 E-mail: zhou6dl@163.com 丁金磊,男,副主任医师,研究方向:肺癌。 E-mail: dingjinlei_dmu@163.com
  • 作者简介:苏洋,男,主治医师,研究方向:麻醉。
  • 基金资助:
    国家自然科学基金(82102771);辽宁省教育厅青年科技人才育苗专项基金(LZ2020061)

Effects of esketamine combined with sufentanil on postoperative analgesia and emotion after thoracoscopic radical resection of lung cancer

SU Yang, ZHOU Feng, DING Jinlei   

  1. Department of Anesthesiology, Second Affiliated Hospital of Dalian Medical University, Dalian 11600, Liaoning, China
  • Received:2022-10-28 Revised:2022-12-20 Online:2023-01-26 Published:2023-02-14

摘要:

目的:观察艾司氯胺酮复合舒芬太尼自控镇痛对胸腔镜肺癌根治术后镇痛及情绪的影响。方法:选取择期行胸腔镜肺癌根治术患者108例,随机数字表法分为3组:艾司氯胺酮复合舒芬太尼自控镇痛组(S组)、低剂量舒芬太尼自控镇痛组(LC组)和高剂量舒芬太尼自控镇痛组(HC组)。术毕行经静脉自控镇痛(PCIA),S组镇痛泵配方:艾司氯胺酮1.2 mg/kg、舒芬太尼1 μg/kg;LC组镇痛泵配方:舒芬太尼1 μg/kg;HC组镇痛泵配方:舒芬太尼1.5 μg/kg;三组镇痛泵均加入托烷司琼10 mg,生理盐水稀释至 100 mL。观察两组患者术后6 h(T1)、12 h(T2)、24 h(T3)和48 h(T4)静息及运动疼痛视觉模拟评分(VAS)和Ramsay镇静评分,评估并记录术前24 h(T0)、术后24 h(T3)、48 h(T4)、72 h(T5)和7 d(T6)患者焦虑自评量表(SAS)、抑郁自评量表(SDS)评分。记录患者补救镇痛次数、术后48 h内镇痛泵有效按压次数,无效按压次数,记录不良反应发生情况。结果:焦虑方面,T0三组SAS评分无差异,S组和HC组T3、T4的SAS评分低于LC组(均P<0.05),T5、T6的三组SAS评分无统计学差异(均P>0.05);抑郁方面,T0三组抑郁人数无统计学差异(P>0.05),S组T3、T4、T5抑郁人数少于LC组和HC组(均P<0.05),T6三组抑郁人数无统计学差异(P>0.05);镇痛方面,T1三组静息及运动VAS评分无统计学差异(均P>0.05),S组和HC组T2、T3、T4静息及运动VAS评分均低于LC组(均P<0.05),术后48 h内的PCIA自控次数和无效按压次数LC组高于S组和HC组(P<0.05),三组在术后疼痛补救次数无明显差异;不良反应方面,S组和LC组在恶心、呕吐、皮肤瘙痒优于HC组(均P<0.05),三组在嗜睡、呼吸抑制、分离症状和噩梦方面无统计学差异。结论:艾司氯胺酮复合舒芬太尼用于胸腔镜肺癌根治术后镇痛可有效降低术后患者的抑郁及焦虑评分,镇痛效果良好,不增加不良反应发生率。

关键词: 艾司氯胺酮, 自控静脉镇痛, 胸腔镜, 肺癌, 情绪

Abstract:

AIM: To observe the effect of Esketamine combined with sufentanil on analgesia and emotion after thoracoscopic radical resection of lung cancer. METHODS: A total of 108 patients undergoing thoracoscopic radical resection of lung cancer were randomly divided into three groups: Esketamine plus sufentanil patient-controlled analgesia group (S group), low-dose sufentanil patient-controlled analgesia group (LC group) and high-dose sufentanil patient-controlled analgesia group (HC group). PCIA was performed after operation. The formula of analgesia pump in group S: Esketamine 1.2 mg/kg, sufentanil 1 μg/kg, LC group analgesic pump formula: sufentanil 1 μg/kg; Formula of analgesic pump in HC group: sufentanil 1.5 μg/kg; Tropisetron 10 mg was added to three groups of analgesia pumps, and normal saline was diluted to 100 mL. Observe the visual analogue scale (VAS) and Ramsay sedation score of resting and exercise pain at 6 h (T1), 12 h (T2), 24 h (T3) and 48 h (T4) after surgery in both groups, evaluate and record the scores of SAS and SDS at 24 h (T0) before surgery, 24 h (T3), 48 h (T4), 72 h (T5) after surgery, and 7 d (T6) after surgery. Record the times of rescue analgesia, the times of effective pressing of the analgesia pump within 48 hours after operation, the times of ineffective pressing, and the occurrence of adverse reactions. RESULTS: In terms of anxiety, there was no difference in SAS scores among the three groups of T0. The SAS scores of T3 and T4 in S group and HC group were lower than those in LC group (all P<0.05). The SAS scores of T5 and T6 in the three groups were not statistically significant (all P>0.05); In terms of depression, the number of patients with depression in T0 group was not statistically significant (P>0.05), the number of patients with depression in T3, T4, T5 in AS group was less than that in LC group and HC group (P<0.05), and the number of patients with depression in T6 group was not statistically significant (P>0.05); In terms of analgesia, the VAS scores of rest and exercise in T1 group were not statistically significant (all P>0.05). The VAS scores of T2, T3, T4 in S group and HC group were lower than those in LC group (all P<0.05). The times of PCIA self-control and ineffective pressing in LC group within 48 hours after surgery were higher than those in S group and HC group (P<0.05). There was no significant difference in the times of pain relief in the three groups after surgery; In terms of adverse reactions, nausea, vomiting and skin itching in group S and LC were better than those in group HC (all P<0.05). There was no statistical significance in terms of sleepiness, respiratory depression, separation symptoms and nightmares in the three groups. CONCLUSION: Esketamine combined with sufentanil for postoperative analgesia after thoracoscopic radical resection of lung cancer can effectively reduce the scores of depression and anxiety of patients, with good analgesic effect and no increase in the incidence of adverse reactions.

Key words: esketamine, patient-controlled intravenous analgesia, thoracoscopy, lung cancer, emotion

中图分类号: